Journal of Nuclear Medicine · 2023 · 48 citations · 2 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic Nuclear MedicineRadionuclide TherapyPositron Emission TomographyRadiobiological ConsiderationsRadiopharmaceutical TherapyRadiopharmaceuticalsTargeted Radionuclide TherapyTheranostic ImagingBeta-emitting Radioligand TherapyBeta-emitting RadionuclidesRadioligand ImagingRadioligand PharmacokineticsRadioligand Therapy ImagingRadionuclide Uptake QuantificationTargeted Radioligand TherapyTheranostic Radiopharmaceuticals
Terbium-161 is a β-emitting radionuclide that resembles 177Lu in terms of its in vivo and in vitro chemical and pharmacokinetic properties, exhibiting similar behavior with regard to radioligand-specific cell uptake and internalization, as well as emitting a modest fraction of photons useful for
2